Key facts
- It has raised $3.9M; the latest was Seed Round ($3.9M) in May 2025.
- Notable investors include SOSV, Impact Assets, IndieBio, Arben Ventures, Astanor — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Metabolic Psychiatry Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Metabolic Psychiatry Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Metabolic Psychiatry Labs
Operator of a healthcare platform intended to treat mental illnesses. The company's platform utilizes a clinical algorithm that integrates metabolic and mental health research, data tracking, metabolic interventions, and personalized check-ins with a medical care team to treat mental illnesses remotely, enabling patients to avail of effective treatments from the comfort of their homes.
- Sector
- Healthcare
- HQ
- Menlo Park, CA, United States
- Founded
- 2024
- Employees
- 6
- Website
- metabolicpsychiatrylabs.com/
- Ownership
- Privately Held (backing)
Metabolic Psychiatry Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Metabolic Psychiatry Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Metabolic Psychiatry Labs in its N-PORT filings yet. We sweep new filings monthly.